ARTICLE | Clinical News
CDA: Phase III started
July 31, 2006 7:00 AM UTC
GSK started a double-blind, African Phase III trial in 900 patients to compare CDA to GSK's Lapdap, a combination of chlorproguanil hydrochloride and dapsone. GSK is developing CDA with the Medicines ...